India reported lowest daily rise in coronavirus cases since early March with 14,146 fresh infections. 144 deaths were recorded in the country due to coronavirus, which took the total death count to 4,52,124.The number of active cases have declined to 1,95,846 and comprise 0.57 per cent of the total infections.
The national COVID-19 recovery rate was recorded at 98.10 per cent, highest since March 2020. 19,788 recoveries in the last 24 hours took the total number of recoveries to 3,34,19,749 in India.The daily positivity rate – number of positive cases identified per 100 – stands at 1.29 per cent, less than 3 per cent for last 48 days. The weekly positivity rate stands at 1.42 per cent in India.
A total of 11,00,123 tests were conducted on Saturday, taking the cumulative tests conducted so far to 59,09,35,381 in the country.
Over 97.65 crore COVID-19 vaccine doses have been administered in the country so far under the nationwide vaccination drive. 41,20,772 coronavirus vaccine doses have been administered in the last 24 hours.
With fears of an impending third wave, the Centre has warned that the next three months would be critical for India. The government has also launched the ‘Covid Mission 100 days’ urging people to not let their guard down.
Delhi reported 21 new COVID-19 cases in the last 24 hours. There are 326 active covid cases in the city.Maharashtra on Saturday reported 1,553 coronavirus positive cases and 26 deaths while 1,682 patients recovered, the state health department said.
The novel coronavirus has killed at least 4,683,586 people since the outbreak emerged in China in December 2019, according to reports. The US is the worst-affected country with 673,474 deaths from 42,050,907 cases.
An expert committee recommended a booster dose of Moderna’s anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot. The booster can be administered six months after the second injection of Moderna’s vaccine. A Moderna representative told the panel the booster would help combat the Delta variant, at a time when vaccine effectiveness has been observed to decline over time against infection and mild cases of the disease, even though it remains effective against severe cases.